Investing Profile

Klaus Veitinger

InvestorVC
Venture Partner at Orbimed
orbimed.comNew York, New York
Photo of Klaus Veitinger, Venture Partner at OrbiMed
cb
OrbiMed Venture Partner
$1M - $75.0M
$4.0M
7
$18B
CompanyStageDateRound SizeTotal Raised
Sparrow Pharmaceuticals
Series UnknownApr 2024$10M
Series AMay 2021$50M
$60M
Alpheus Medical
Series ANov 2022$14M
Series ANov 2021$16M
$30M
Co-investors: Daniel Coley (Cofounders Capital), Imran Eba (Action Potential Venture Capital)
Neurogastrx
Series BAug 2021$60M
Series AJan 2018$45M
$110M
Co-investors: Aaron Royston (venBio), David Allison (Westlake Village BioPartners)
Promentis Pharmaceuticals
Series CMar 2017$26M
$26M